Kenvue

Kenvue Inc.
Company type	Public
Traded as	NYSE: KVUE; S&P 500 component;
Industry	Consumer products
Predecessor	Johnson & Johnson (consumer health division); Pfizer Consumer Health (1st incarnation); Pharmacia & Upjohn (consumer health division);
Founded	February 23, 2022 in Wilmington, Delaware, U.S.
Headquarters	Skillman, New Jersey, U.S.
Area served	Worldwide
Key people	Thibaut Mongon (CEO); Larry Merlo (chairman);
Products	Aveeno; Band-Aid; Benadryl; Combantrin; Johnson's Baby; Listerine; Lactaid; Mylanta; Neutrogena; Trosyd; Calpol; Tylenol; Visine;
Revenue	US$15.5 billion (2024)
Operating income	US$1.84 billion (2024)
Net income	US$1.03 billion (2024)
Total assets	US$25.6 billion (2024)
Total equity	US$9.67 billion (2024)
Number of employees	c. 22,000 (2024)
Subsidiaries	McNeil Consumer Healthcare
Website	kenvue.com
	Footnotes / references;

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine.

Kenvue is incorporated under the Delaware General Corporation Law and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey. Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey.